Senolytics are the first therapies that directly target one of the aging processes in order to delay or prevent age-related diseases, and they are now in human trials. Today, we think that it is the ideal time to have a look at how they work and what... https://t.co/Iopgt1OV5v— Lifespan.IO (@LifespanIO) December 27, 2018
Thursday, December 27, 2018
"Senolytics" now in human trials
- ► 2019 (32)
- ▼ December (4)
- ► 2016 (42)
I urge our govt to develop new growth indicators that will give equal importance to non-economic aspects of well-being http://t.co/vI9ch4fE ...